Envision Healthcare Corporation (NYSE:EVHC) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Thursday.

EVHC has been the subject of several other research reports. Mizuho decreased their target price on Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research report on Wednesday, August 9th. Zacks Investment Research lowered Envision Healthcare Corporation from a “hold” rating to a “strong sell” rating in a research report on Monday, May 8th. Royal Bank Of Canada lifted their target price on Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 27th. Jefferies Group LLC set a $75.00 target price on Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Friday, April 21st. Finally, Cantor Fitzgerald reiterated a “buy” rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare Corporation has an average rating of “Buy” and an average price target of $71.56.

Shares of Envision Healthcare Corporation (NYSE EVHC) traded up 0.66% during midday trading on Thursday, reaching $50.21. The company’s stock had a trading volume of 1,433,281 shares. The firm’s market capitalization is $5.88 billion. The company’s 50-day moving average price is $57.66 and its 200 day moving average price is $60.47. Envision Healthcare Corporation has a 1-year low of $49.56 and a 1-year high of $74.75.

Envision Healthcare Corporation (NYSE:EVHC) last issued its earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.75 by $0.04. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The business’s revenue was up 156.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.34 EPS. On average, equities research analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Envision Healthcare Corporation (EVHC) Rating Lowered to Strong Sell at BidaskClub” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/08/20/envision-healthcare-corporation-evhc-rating-lowered-to-strong-sell-at-bidaskclub.html.

In related news, insider Robert Jon Coward sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total value of $94,035.00. Following the sale, the insider now owns 97,863 shares of the company’s stock, valued at approximately $6,135,031.47. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 3.10% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Macquarie Group Ltd. increased its stake in shares of Envision Healthcare Corporation by 1,075.0% in the fourth quarter. Macquarie Group Ltd. now owns 23,500 shares of the company’s stock valued at $1,488,000 after buying an additional 21,500 shares during the last quarter. Gulf International Bank UK Ltd increased its stake in shares of Envision Healthcare Corporation by 0.8% in the first quarter. Gulf International Bank UK Ltd now owns 36,367 shares of the company’s stock valued at $2,230,000 after buying an additional 300 shares during the last quarter. Capstone Asset Management Co. increased its stake in shares of Envision Healthcare Corporation by 3.0% in the first quarter. Capstone Asset Management Co. now owns 11,147 shares of the company’s stock valued at $684,000 after buying an additional 329 shares during the last quarter. Atria Investments LLC increased its stake in shares of Envision Healthcare Corporation by 31.3% in the first quarter. Atria Investments LLC now owns 5,380 shares of the company’s stock valued at $330,000 after buying an additional 1,282 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Envision Healthcare Corporation by 14,372.5% in the first quarter. Nisa Investment Advisors LLC now owns 28,945 shares of the company’s stock valued at $1,775,000 after buying an additional 28,745 shares during the last quarter. 64.75% of the stock is currently owned by hedge funds and other institutional investors.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.